Goals of treatment for Paget's disease of bone

Journal of Bone and Mineral Research

Volumn 14, Issue SUPPL. 2, 1999, Pages 49-52

  Siris, Ethel S ^a,b  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; ETIDRONIC ACID; PAMIDRONIC ACID; RISEDRONIC ACID; SALCATONIN;

ALKALINE PHOSPHATASE BLOOD LEVEL; BONE DISEASE; BONE MALFORMATION; BONE TURNOVER; CLINICAL FEATURE; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFICACY; HUMAN; HYPERTROPHY; OSSIFICATION; PAGET BONE DISEASE; REMISSION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 0032858955     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbmr.5650140211     Document Type: Conference Paper

References (30)

1. Ryan WG, Schwartz TB, Perlia CP 1969 Effects of mithramycin on Paget's disease of bone. Ann Intern Med 70:549-557.
2. DeRose J, Singer F, Avramides A, Flores A, Dziadiw R, Baker R, Wallach S 1974 Response of Paget's disease to porcine and salmon calcitonins. Am J Med 56:858-866.
3. Smith R, Russell RGG, Bishop M 1971 Diphosphonates and Paget's disease of bone. Lancet 1:945-947.
4. Altman RD, Johnston CC, Khairi MRA, Wellman H, Serafini AN, Sankey RR 1973 Influence of disodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans). N Engl J Med 189:1379-1384.
5. Canfield R, Rosner Skinner J, McWhorter J, Resnick L, Feldman F, Kammerman S, Ryan K, Kunigonis M, Bohne W 1977 Diphosphonate therapy of Paget's disease of bone. J Clin Endocrinol Metab 44:96-106.
6. el Sammaa M, Linthicum FH Jr, House HP, House JW 1986 Calcitonin as treatment for hearing loss in Paget's disease. Am J Otol 7:241-243.
7. Siris ES 1991 Indications for medical treatment for Paget's disease of bone. In: Singer FR, Wallach S (eds.) Paget's Disease of Bone. Clinical Assessment, Present and Future Therapy. Elsevier, New York, NY, U.S.A., pp. 44-56.
8. Meunier PJ, Vignot E 1995 Therapeutic strategy in Paget's disease of bone. Bone 17:489S-491S.
9. Mautalen CA, Gonzalez D, Ghiringhelli G 1985 Efficacy of the bisphosphonate APD in the control of Paget's bone disease. Bone 6:429-432.
10. Harinck HI, Papapoulos SE, Blanksma HJ, Moolenaar AJ, Vermeij P, Bijvoet OL 1987 Paget's disease of bone: Early and late responses to three different modes of treatment with aminohydroxypropylidine bisphosphonate (APD). Br Med J 295:1301-1305.
11. Siris E, Weinstein RS, Altman R, Conte JM, Favus M, Lombardi A, Lyles K, McIlwain H, Murphy WA, Reda R, Rude R, Seton M, Tiegs R, Thompson D, Tucci JR, Yates AJ, Zimring M 1996 Comparative study of alendronate versus etidronate for the treatment of Paget's disease of bone. J Clin Endocrinol Metab 81:961-967.
12. Reid IR, Nicholson GC, Weinstein RS, Hosking D, Cundy T, Kotowicz MA, Murphy WA, Yeap S, Dufresne S, Lombardi A, Musliner TA, Thompson DE, Yates AJ 1996 Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: A randomized, placebo-controlled trial. Am J Med 101:341-348.
13. Khan SA, Vasikaran S, McKloskey EV, Beneton EV, Rogers S, Coulton L, Orgee J, Coombes G, Kanis JA 1997 Alendronate in the treatment of Paget's disease of bone. Bone 20:263-271.
14. Siris ES, Chines AA, Altman RD, Brown JP, Johnston CC, Lang R, McClung MR, Mallette LE, Miller PD, Ryan WG, Singer FR, Tucci JR, Eusebio RA, Bekker PJ 1998 Risedronate in the treatment of Paget's disease: an open-label multicenter study. J Bone Miner Res 13:1032-1038.
15. Miller PD, Brown JP, Siris ES, Hoseyni MS, Axelrod DW, Bekker PJ 1999 A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Am J Med 106:513-520.
16. Nicholson G, Lyles K, Reid I, Rude R, Siris E, Tucci J, Lombardi A, Reyes R 1998 Long-term remission induced by alendronate treatment of Paget's disease. Bone 23:S454.
17. Kanis JA, Grey RES 1987 Long-term follow-up observations on treatment of Paget's disease of bone. Clin Orthop 217:99-125.
18. Adamson BB, Gallacher SJ, Byars J, Ralston SH, Boyle IT, Boyce BF 1993 Mineralisation defects after pamidronate in Paget's disease. Lancet 342:1459-1460.
19. Kantrowitz FG, Byrne MH, Schiller AL, Krane SM 1975 Clinical and biochemical effects of diphosphonate in Paget's disease of bone. Arthritis Rheum 18:407.
20. Melton LJ III, Chrischilles EA, Cooper C, Lane AW, Riggs BL 1992 Perspective: How many women have osteoporosis? J Bone Miner Res 7:1005-1010.
21. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM, for the Study of Osteoporotic Fractures Research Group 1993 Bone density at various sites for prediction of hip fractures. Lancet 341:72-75.
22. Kanis JA 1998 Pathophysiology and Treatment of Paget's Disease of Bone. 2nd edn. Martin Dunitz, London, U.K.
23. Siris ES, Feldman F 1997 Clinical vignette: Natural history of untreated Paget's disease of the tibia. J Bone Miner Res 12:691-692.
24. Maldague B, Malghem J 1987 Dynamic radiologic patterns of Paget's disease of bone. Clin Orthop 217:126-151.
25. Altman RD 1985 Long-term follow up of therapy with intermittent etidronate disodium in Paget's disease of bone. Am J Med 79:583-590.
26. Johnston CC, Khairi MRA, Canfield RE, Finerman GAM, Taulbee JD, Ebert ML 1983 Review of fracture experience during treatment of Paget's disease of bone with etidronate disodium (EHDP). Clin Orthop 172:186-194.
27. Bickerstaff DR, Douglas DL, Burke PH, O'Doherty DP, Kanis JA 1990 Improvement in facial deformity of Paget's disease treated with diphosphonates. J Bone Joint Surg Br 72:132-136.
28. Cundy T, Wattie D, King AR 1996 High dose pamidronate in the treatment of resistant Paget's disease. Calcif Tissue Int 58:6-8.
29. Siris ES, Canfield RE, Jacobs TP, Stoddart K, Spector PJ 1981 Clinical and biochemical effects of EHDP in Paget's disease of bone: Pattern of response to initial treatment and to long-term therapy. Metab Bone Dis Rel Res 4-5:301-308.
30. Gutteridge DH, Ward LC, Stewart GO, Retallack RW, Prince RL, Bhagat CI, Stuckey BGA, Will RK, Kent GN, Price RI, Gan SK 1999 A randomised treatment trial of IV pamidronate and oral alendronate in Paget's disease - Early results. Bone 24:67S-68S.